Leveraging molecular heterogeneity of the vascular endothelium for targeted drug delivery and imaging

Seminars in Thrombosis and Hemostasis

Volumn 36, Issue 3, 2010, Pages 343-351

  Pasqualini, Renata ^a   Moeller, Benjamin J ^a   Arap, Wadih ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Phage display; Targeting; Vasculature

Indexed keywords

CELL SURFACE RECEPTOR; GOLD NANOPARTICLE; HYBRID PROTEIN; IMMUNOGLOBULIN; LIGAND; PARVOVIRUS VECTOR; PEPTIDE; PROHIBITIN; UNCLASSIFIED DRUG; WHITE FAT HOMING PEPTIDE;

BACTERIOPHAGE; BIOPANNING; BIOPANNING AND RAPID ANALYSIS OF SELECTIVE INTERACTIVE LIGAND; CELL FREE SYSTEM; CELL SURFACE; CELL SUSPENSION; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; LIGAND BINDING; MOLECULAR IMAGING; MOLECULAR LIBRARY; NANOTECHNOLOGY; NONHUMAN; OBESITY; PHAGE DISPLAY; PHASE SEPARATION; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; RECEPTOR BINDING; REVIEW; SCREENING; VASCULAR ENDOTHELIUM;

DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; ENDOTHELIUM, VASCULAR; HUMANS; LIGANDS; VASCULAR DISEASES;

EID: 77953249786     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0030-1253456     Document Type: Review

References (78)

1. Pasqualini R, Ruoslahti E. Organ targeting in vivo using phage display peptide libraries. Nature 1996 380 (6572) 364-366
2. Rajotte D, Arap W, Hagedorn M, Koivunen E, Pasqualini R, Ruoslahti E. Molecular heterogeneity of the vascular endothelium revealed by in vivo phage display. J Clin Invest 1998 102 (2) 430-437
3. Salmi M, Jalkanen S. How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv Immunol 1997 64 139-218
4. Springer T A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994 76 (2) 301-314
5. Katayama Y, Hidalgo A, Furie B C., Vestweber D, Furie B, Frenette P S. PSGL-1 participates in E-selectin-mediated progenitor homing to bone marrow: evidence for cooperation between E-selectin ligands and alpha4 integrin. Blood 2003 102 (6) 2060-2067
6. Lapidot T, Dar A, Kollet O. How do stem cells find their way home? Blood 2005 106 (6) 1901-1910
7. Hanahan D, Weinberg R A. The hallmarks of cancer. Cell 2000 100 (1) 57-70
8. Folkman J. What is the role of endothelial cells in angiogenesis? Lab Invest 1984 51 (6) 601-604
9. Gibbs W J., Drew R H., Perfect J R. Liposomal amphotericin B: clinical experience and perspectives. Expert Rev Anti Infect Ther 2005 3 (2) 167-181
10. Stavridi F, Palmieri C. Efficacy and toxicity of nonpegylated liposomal doxorubicin in breast cancer. Expert Rev Anticancer Ther 2008 8 (12) 1859-1869
11. Arap M A., Lahdenranta J, Mintz P J. et al. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 2004 6 (3) 275-284
12. Arap W, Haedicke W, Bernasconi M et al. Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci U S A 2002 99 (3) 1527-1531
13. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998 279 (5349) 377-380
14. Giordano R J., Lahdenranta J, Zhen L et al. Targeted induction of lung endothelial cell apoptosis causes emphysema-like changes in the mouse. J Biol Chem 2008 283 (43) 29447-29460
15. Hajitou A, Trepel M, Lilley C E. et al. A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell 2006 125 (2) 385-398
16. Kolonin M G., Saha P K., Chan L, Pasqualini R, Arap W. Reversal of obesity by targeted ablation of adipose tissue. Nat Med 2004 10 (6) 625-632
17. Lahdenranta J, Sidman R L., Pasqualini R, Arap W. Treatment of hypoxia-induced retinopathy with targeted proapoptotic peptidomimetic in a mouse model of disease. FASEB J 2007 21 (12) 3272-3278 (Pubitemid 47565545)
18. Oh P, Li Y, Yu J et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature 2004 429 (6992) 629-635
19. Paoloni M C., Tandle A, Mazcko C et al. Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculature. PLoS One 2009 4 (3) e4972
20. Veenendaal L M., Jin H, Ran S et al. In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors. Proc Natl Acad Sci U S A 2002 99 (12) 7866-7871
21. Zurita A J., Troncoso P, Cardó-Vila M, Logothetis C J., Pasqualini R, Arap W. Combinatorial screenings in patients: the interleukin-11 receptor alpha as a candidate target in the progression of human prostate cancer. Cancer Res 2004 64 (2) 435-439
22. Carson-Walter E B., Watkins D N., Nanda A, Vogelstein B, Kinzler K W., St Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 2001 61 (18) 6649-6655
23. St Croix B, Rago C, Velculescu V et al. Genes expressed in human tumor endothelium. Science 2000 289 (5482) 1197-1202
24. Roesli C, Neri D, Rybak J N. In vivo protein biotinylation and sample preparation for the proteomic identification of organ-and disease-specific antigens accessible from the vasculature. Nat Protoc 2006 1 192-199
25. Scott J K., Smith G P. Searching for peptide ligands with an epitope library. Science 1990 249 (4967) 386-390
26. Smith G P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985 228 (4705) 1315-1317
27. Smith G P., Scott J K. Libraries of peptides and proteins displayed on filamentous phage. Methods Enzymol 1993 217 228-257
28. Jaalouk D E., Ozawa M G., Sun J et al. The original Pathologische Anatomie Leiden-Endothelium monoclonal antibody recognizes a vascular endothelial growth factor binding site within neuropilin-1. Cancer Res 2007 67 (20) 9623-9629
29. Mintz P J., Kim J, Do K A. et al. Fingerprinting the circulating repertoire of antibodies from cancer patients. Nat Biotechnol 2003 21 (1) 57-63
30. Vidal C I., Mintz P J., Lu K et al. An HSP90-mimic peptide revealed by fingerprinting the pool of antibodies from ovarian cancer patients. Oncogene 2004 23 (55) 8859-8867
31. Barker T H., Baneyx G, Cardó-Vila M et al. SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem 2005 280 (43) 36483-36493
32. Cardó-Vila M, Arap W, Pasqualini R. Alpha v beta 5 integrin-dependent programmed cell death triggered by a peptide mimic of annexin V. Mol Cell 2003 11 (5) 1151-1162
33. Kato-Takagaki K, Mizukoshi Y, Yoshizawa Y et al. Structural and interaction analysis of glycoprotein VI-binding peptide selected from a phage display library. J Biol Chem 2009 284 (16) 10720-10727
34. Koivunen E, Arap W, Valtanen H et al. Tumor targeting with a selective gelatinase inhibitor. Nat Biotechnol 1999 17 (8) 768-774
35. Kzhyshkowska J, Workman G, Cardó-Vila M et al. Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J Immunol 2006 176 (10) 5825-5832
36. O'Neil K T., Hoess R H., Jackson S A., Ramachandran N S., Mousa S A., DeGrado W F. Identification of novel peptide antagonists for GPIIb/IIIa from a conformationally constrained phage peptide library. Proteins 1992 14 (4) 509-515
37. Smith G P., Schultz D A., Ladbury J E. A ribonuclease S-peptide antagonist discovered with a bacteriophage display library. Gene 1993 128 (1) 37-42
38. Tamm I, Trepel M, Cardó-Vila M et al. Peptides targeting caspase inhibitors. J Biol Chem 2003 278 (16) 14401-14405
39. Koivunen E, Wang B, Ruoslahti E. Isolation of a highly specific ligand for the alpha 5 beta 1 integrin from a phage display library. J Cell Biol 1994 124 (3) 373-380
40. McConnell S J., Dinh T, Le M H. et al. Isolation of erythropoietin receptor agonist peptides using evolved phage libraries. Biol Chem 1998 379 (10) 1279-1286
41. Goodson R J., Doyle M V., Kaufman S E., Rosenberg S. High-affinity urokinase receptor antagonists identified with bacteriophage peptide display. Proc Natl Acad Sci U S A 1994 91 (15) 7129-7133
42. Doorbar J, Winter G. Isolation of a peptide antagonist to the thrombin receptor using phage display. J Mol Biol 1994 244 (4) 361-369
43. Gui J, Moyana T, Malcolm B, Xiang J. Identification of a decapeptide with the binding reactivity for tumor-associated TAG72 antigen from a phage displayed library. Proteins 1996 24 (3) 352-358
44. Fukuda M N., Ohyama C, Lowitz K et al. A peptide mimic of E-selectin ligand inhibits sialyl Lewis X-dependent lung colonization of tumor cells. Cancer Res 2000 60 (2) 450-456
45. Giordano R J., Cardó-Vila M, Lahdenranta J, Pasqualini R, Arap W. Biopanning and rapid analysis of selective interactive ligands. Nat Med 2001 7 (11) 1249-1253
46. Nishimura S, Takahashi S, Kamikatahira H et al. Combinatorial targeting of the macropinocytotic pathway in leukemia and lymphoma cells. J Biol Chem 2008 283 (17) 11752-11762
47. Giordano R J., Anobom C D., Cardó-Vila M et al. Structural basis for the interaction of a vascular endothelial growth factor mimic peptide motif and its corresponding receptors. Chem Biol 2005 12 (10) 1075-1083
48. Folkman J. Fundamental concepts of the angiogenic process. Curr Mol Med 2003 3 (7) 643-651
49. Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov 2007 6 (4) 273-286 (Pubitemid 46505878)
50. Kolonin M G., Bover L, Sun J et al. Ligand-directed surface profiling of human cancer cells with combinatorial peptide libraries. Cancer Res 2006 66 (1) 34-40
51. Arap M A., Lahdenranta J, Hajitou A et al. Model of unidirectional transluminal gene transfer. Mol Ther 2004 9 (2) 305-310
52. Ardelt P U., Wood C G., Chen L et al. Targeting urothelium: ex vivo assay standardization and selection of internalizing ligands. J Urol 2003 169 (4) 1535-1540
53. Shukla G S., Krag D N. Selection of tumor-targeting agents on freshly excised human breast tumors using a phage display library. Oncol Rep 2005 13 (4) 757-764
54. Lewis V O., Ozawa M G., Deavers M T. et al. The interleukin-11 receptor alpha as a candidate ligand-directed target in osteosarcoma: consistent data from cell lines, orthotopic models, and human tumor samples. Cancer Res 2009 69 (5) 1995-1999
55. Yao V J., Ozawa M G., Trepel M, Arap W, McDonald D M., Pasqualini R. Targeting pancreatic islets with phage display assisted by laser pressure catapult microdissection. Am J Pathol 2005 166 (2) 625-636
56. Gordon P H., Moore D H., Miller R G. et al, Western ALS Study Group. Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 2007 6 (12) 1045-1053
57. Benatar M. Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol Dis 2007 26 (1) 1-13
58. Arap W, Kolonin M G., Trepel M et al. Steps toward mapping the human vasculature by phage display. Nat Med 2002 8 (2) 121-127
59. Pentz R D., Flamm A L., Pasqualini R, Logothetis C J., Arap W. Revisiting ethical guidelines for research with terminal wean and brain-dead participants. Hastings Cent Rep 2003 33 (1) 20-26
60. Kolonin M G., Sun J, Do K A. et al. Synchronous selection of homing peptides for multiple tissues by in vivo phage display. FASEB J 2006 20 (7) 979-981
61. Hajitou A, Pasqualini R, Arap W. Vascular targeting: recent advances and therapeutic perspectives. Trends Cardiovasc Med 2006 16 (3) 80-88
62. Kolonin M, Pasqualini R, Arap W. Molecular addresses in blood vessels as targets for therapy. Curr Opin Chem Biol 2001 5 (3) 308-313
63. Ozawa M G., Zurita A J., Dias-Neto E et al. Beyond receptor expression levels: the relevance of target accessibility in ligand-directed pharmacodelivery systems. Trends Cardiovasc Med 2008 18 (4) 126-132
64. Pasqualini R, Arap W. Profiling the molecular diversity of blood vessels. Cold Spring Harb Symp Quant Biol 2002 67 223-225
65. Trepel M, Arap W, Pasqualini R. In vivo phage display and vascular heterogeneity: implications for targeted medicine. Curr Opin Chem Biol 2002 6 (3) 399-404
66. Trepel M, Pasqualini R, Arap W. Chapter 4. Screening phage-display Peptide libraries for vascular targeted peptides. Methods Enzymol 2008 445 83-106
67. Neri D, Bicknell R. Tumour vascular targeting. Nat Rev Cancer 2005 5 (6) 436-446
68. Hajitou A, Lev D C., Hannay J A. et al. A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging. Proc Natl Acad Sci U S A 2008 105 (11) 4471-4476
69. Hajitou A, Rangel R, Trepel M et al. Design and construction of targeted AAVP vectors for mammalian cell transduction. Nat Protoc 2007 2 523-531
70. Souza G R., Yonel-Gumruk E, Fan D et al. Bottom-up assembly of hydrogels from bacteriophage and Au nanoparticles: the effect of cis-and trans-acting factors. PLoS One 2008 3 (5) e2242
71. Souza G R., Christianson D R., Staquicini F I. et al. Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc Natl Acad Sci U S A 2006 103 (5) 1215-1220
72. Souza G R., Levin C S., Hajitou A, Pasqualini R, Arap W, Miller J H. In vivo detection of gold-imidazole self-assembly complexes: NIR-SERS signal reporters. Anal Chem 2006 78 (17) 6232-6237
73. Barbas C, Burton D, Silverman G, Scott J. Phage Display: A Laboratory Manual. New York, NY Cold Spring Harbor Laboratory Press 2001
74. Marchiò S, Lahdenranta J, Schlingemann R O. et al. Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell 2004 5 (2) 151-162
75. Koivunen E, Wang B, Ruoslahti E. Phage libraries displaying cyclic peptides with different ring sizes: ligand specificities of the RGD-directed integrins. Biotechnology (N Y) 1995 13 (3) 265-270
76. Pasqualini R, Koivunen E, Kain R et al. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 2000 60 (3) 722-727
77. Mintz P J., Cardó-Vila M, Ozawa M G. et al. An unrecognized extracellular function for an intracellular adapter protein released from the cytoplasm into the tumor microenvironment. Proc Natl Acad Sci U S A 2009 106 (7) 2182-2187
78. Burg M A., Pasqualini R, Arap W, Ruoslahti E, Stallcup W B. NG2 proteoglycan-binding peptides target tumor neovasculature. Cancer Res 1999 59 (12) 2869-2874